© 2020 MJH Life Sciences and Practical Cardiology. All rights reserved.
December 13, 2017
Which biomarker is most useful in what situation? Find out how one cardiologist makes these decisions. Do you concur?
The PCSK9 inhibitor class is here to stay. Find out what you know about the enzyme and how its inhibition is revolutionizing CHD prevention.
Click through our topline review of the key takeaways from this long-awaited update.
September 20, 2017
Quick Quiz: Which antiplatelet/antithrombin combination provides greatest efficacy with least risk for bleeding?